CoMFA and CoMSIA Analyses of Novel Chromenone Derivatives as Interleukin 5 Inhibitors
Jordan Journal of Chemistry · 30.08.2023 · 18 (2) · 109-118
DOI: 10.47014/18.2.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jordan Journal of Chemistry, online erschienen am 30.08.2023. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Major allergic diseases are caused by an increased accumulation of eosinophils driven by interleukin 5 (IL-5). Chromenone analogues have been demonstrated as a promising scaffold for IL-5 inhibitors to control allergic diseases. Therefore, the molecular interaction of IL-5 inhibitors with biological targets is important for better drug discovery. In this study, we analysed in vitro data using 3D-QSAR (Quantitative Structure-Activity Relationships) modelling to find the IL-5 inhibitory activity and molecular interaction. The results of Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Field Similarity Indices (CoMSIA IB) revealed that the in vitro IL-5 inhibitory activity of these chromenone derivatives exhibited strong correlations with steric and electrostatic factors of the molecules (q2 =0.503, r_ncv^2 = 0.997, and r_bs^2 = 0.989 for CoMFA standard model and q2 =0.623, r_ncv^2 = 0.973, and r_bs^2 = 0.990 for CoMSIA model). 3D-QSAR field contour maps could be generated to identify the important structural features of chromenone analogues relevant to the IL-5 inhibitory activity.
Zitieren
APA
(2023). CoMFA and CoMSIA Analyses of Novel Chromenone Derivatives as Interleukin 5 Inhibitors. Jordan Journal of Chemistry, 18(2), 109-118. https://doi.org/10.47014/18.2.5
Vancouver
CoMFA and CoMSIA Analyses of Novel Chromenone Derivatives as Interleukin 5 Inhibitors. Jordan Journal of Chemistry. 2023;18(2):109-118. doi:10.47014/18.2.5
BibTeX
@article{euvimed2023,
title = {CoMFA and CoMSIA Analyses of Novel Chromenone Derivatives as Interleukin 5 Inhibitors},
journal = {Jordan Journal of Chemistry},
year = {2023},
volume = {18},
number = {2},
pages = {109--118},
doi = {10.47014/18.2.5}
}
EUVIMED